Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Tumor immune evasion arises through loss of TNF sensitivity.

Kearney CJ, Vervoort SJ, Hogg SJ, Ramsbottom KM, Freeman AJ, Lalaoui N, Pijpers L, Michie J, Brown KK, Knight DA, Sutton V, Beavis PA, Voskoboinik I, Darcy PK, Silke J, Trapani JA, Johnstone RW, Oliaro J.

Sci Immunol. 2018 May 18;3(23). pii: eaar3451. doi: 10.1126/sciimmunol.aar3451.

PMID:
29776993
2.

BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1.

Hogg SJ, Vervoort SJ, Deswal S, Ott CJ, Li J, Cluse LA, Beavis PA, Darcy PK, Martin BP, Spencer A, Traunbauer AK, Sadovnik I, Bauer K, Valent P, Bradner JE, Zuber J, Shortt J, Johnstone RW.

Cell Rep. 2017 Feb 28;18(9):2162-2174. doi: 10.1016/j.celrep.2017.02.011.

3.

Development of single and mixed isoform selectivity PI3Kδ inhibitors by targeting Asn836 of PI3Kδ.

Miller MS, Mountford SJ, Pinson JA, Zheng Z, Künzli M, Patel V, Hogg SJ, Shortt J, Jennings IG, Thompson PE.

Bioorg Med Chem Lett. 2016 Oct 1;26(19):4790-4794. doi: 10.1016/j.bmcl.2016.08.028. Epub 2016 Aug 11.

PMID:
27561716
4.

BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members.

Hogg SJ, Newbold A, Vervoort SJ, Cluse LA, Martin BP, Gregory GP, Lefebure M, Vidacs E, Tothill RW, Bradner JE, Shortt J, Johnstone RW.

Mol Cancer Ther. 2016 Sep;15(9):2030-41. doi: 10.1158/1535-7163.MCT-15-0924. Epub 2016 Jul 12.

5.

The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock.

West AC, Martin BP, Andrews DA, Hogg SJ, Banerjee A, Grigoriadis G, Johnstone RW, Shortt J.

Oncogenesis. 2016 Apr 4;5:e216. doi: 10.1038/oncsis.2016.26.

6.

Resveratrol, Acetyl-Resveratrol, and Polydatin Exhibit Antigrowth Activity against 3D Cell Aggregates of the SKOV-3 and OVCAR-8 Ovarian Cancer Cell Lines.

Hogg SJ, Chitcholtan K, Hassan W, Sykes PH, Garrill A.

Obstet Gynecol Int. 2015;2015:279591. doi: 10.1155/2015/279591. Epub 2015 Nov 5.

7.

A method to investigate the anti-metabolic activity of anti-cancer agents on ovarian cancer cells cultured in a 96-well high throughput format.

Hogg SJ, Evans JJ, Sykes PH, Chitcholtan K.

J Ovarian Res. 2015 Jul 4;8:43. doi: 10.1186/s13048-015-0172-0.

8.

CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo.

Gregory GP, Hogg SJ, Kats LM, Vidacs E, Baker AJ, Gilan O, Lefebure M, Martin BP, Dawson MA, Johnstone RW, Shortt J.

Leukemia. 2015 Jun;29(6):1437-41. doi: 10.1038/leu.2015.10. Epub 2014 Jan 12. No abstract available.

9.

Letter to the Editor, "BET inhibitor JQ1 blocks inflammation and bone destruction".

Hogg SJ, Johnstone RW, Shortt J.

J Dent Res. 2015 Jan;94(1):229. doi: 10.1177/0022034514557673. Epub 2014 Nov 11. No abstract available.

PMID:
25389001
10.

The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.

Shortt J, Hsu AK, Martin BP, Doggett K, Matthews GM, Doyle MA, Ellul J, Jockel TE, Andrews DM, Hogg SJ, Reitsma A, Faulkner D, Bergsagel PL, Chesi M, Heath JK, Denny WA, Thompson PE, Neeson PJ, Ritchie DS, McArthur GA, Johnstone RW.

Cell Rep. 2014 May 22;7(4):1009-19. doi: 10.1016/j.celrep.2014.04.008. Epub 2014 May 9.

11.

Distribution of Pt in the urine and kidney of the cisplatin treated rat.

Mason RW, Hogg SJ, Edwards IR.

Toxicology. 1986 Feb;38(2):219-26.

PMID:
3945972
12.

Reconstruction following seismic disaster in venzone, friuli.

Hogg SJ.

Disasters. 1980 Jun;4(2):173-85. doi: 10.1111/j.1467-7717.1980.tb00271.x. No abstract available.

PMID:
20958465

Supplemental Content

Support Center